methazolamide has been researched along with Metabolic Diseases in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Li, Z | 1 |
Peng, M | 1 |
Chen, P | 1 |
Liu, C | 1 |
Hu, A | 1 |
Zhang, Y | 2 |
Peng, J | 1 |
Liu, J | 1 |
Li, Y | 1 |
Li, W | 1 |
Zhu, W | 1 |
Guan, D | 1 |
Chen, H | 1 |
Li, J | 1 |
Fan, D | 1 |
Huang, K | 1 |
Lin, F | 1 |
Zhang, Z | 1 |
Guo, Z | 1 |
Luo, H | 1 |
He, X | 1 |
Zhu, Y | 1 |
Li, L | 1 |
Huang, B | 1 |
Cai, W | 1 |
Gu, L | 1 |
Lu, Y | 1 |
Deng, K | 1 |
Yan, L | 1 |
Chen, S | 1 |
1 other study available for methazolamide and Metabolic Diseases
Article | Year |
---|---|
Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry.
Topics: Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Chlorocebus aethiops; COVID-19; COVID-19 | 2022 |